Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-438-2 | CAS number: 106-88-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
Propylene oxide (PpO) and butylene oxide (BtO) are not known to produce neuropathy in humans; however, both produced ataxia of the hindleg and distal axonal degeneration of myelinated fibers of the lumbosacral primary sensory neuron in rats. Therefore, both must be considered to be neurotoxic. Although the concentration of PpO and BtO needed to produce neuropathy in rats is much greater than the exposure limits (100 ppm for PpO and not determined for BtO) recommended by the National Institute of Occupational Safety and Health, it cannot be excluded that the substances might cause neuropathies in humans at high concentrations too, but not at the derived DNELs/DMELs.
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via inhalation route
Link to relevant study records
- Endpoint:
- neurotoxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: basic information given
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Based on preliminary studies, test rats were subjected daily to a 6-hr exposure to BtO at a concentration of 2000 ppm, four times a week for 5 months. Systematic clinical and histopathologic studies were performed.
- GLP compliance:
- not specified
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- inhalation
- Duration of treatment / exposure:
- 5 months
- Frequency of treatment:
- 6 h/day, 4 days/week
- Dose / conc.:
- 2 000 ppm
- No. of animals per sex per dose:
- no data
- Control animals:
- yes
- Remarks on result:
- not measured/tested
Reference
Test rats developed mild ataxia in the hindleg in the second and third week of the fifth month of exposure. Test rats were sacrificed at the end of the fifth month of exposure along with the pair-fed control rats. In teased fiber preparations of peroneal, proximal, and distal sural nerves, nerve to soleus muscle, and proximal and distal dorsal caudal trunks, the difference in the frequency of the abnormality between test and control was not statistically significant. In epon-embedded sections, no abnormality of myelinated fibers in test compared with control was found in the limb nerves and the dorsal caudal trunk. Similarly, no abnormality was found in the sixth lumbar and the third sacral dorsal roots and dorsal root ganglion. On the other hand, in fasciculus gracilis, degeneration of myelinated fibers was found in all test rats at the third cervical segment, but not at the fifth thoracic segment. Morphometric evaluation of peroneal nerve and proximal and distal dorsal caudal trunks showed that the transverse fascicular area, myelinated fiber density, myelinated fiber number per nerve, and median and mean diameters of myelinated fibers were all similar between test and control.
The extent of the distribution of the distal degeneration of the myelinated axon in the fasciculus gracilis was analyzed. The centrally directed myelinated axon of the primary sensory neuron seemed to be dying or degenerating back to the fourth cervical segment and down to the third thoracic segment. The densities and the median diameters of myelinated fibers of the dorsomedì.an portion of the fasciculus gracilis at the third cervical and fifth thoracic segments were evaluated. Myelinated fiber density in test was significantly less than that in control only at the third cervical segment. Median diameter was similar between test and control in both segments.
In BtO intoxication, obvious axonal degeneration of myelinated fibers was preferentially found in the dorsal portion of the fasciculus gracilis, where the centrally directed myelinated axon of the lumbosacrococcygeal primary sensory neuron is distributed.
Conclusion
Propylene oxide (PpO) and butylene oxide (BtO) are not known to produce neuropathy in humans; however, both produced ataxia of the hindleg and distal axonal degeneration of myelinated fibers of the lumbosacral primary sensory neuron in rats. Therefore, both must be considered to be neurotoxic. Although the concentration of PpO and BtO needed to produce neuropathy in rats is much greater than the exposure limits (100 ppm for PpO and not determined for BtO) recommended by the National Institute of Occupational Safety and Health, PpO and BtO may cause neuropathies in exposed workers. Recognition of the neurotoxicity of both chemicals seems to be very important for better understanding the relationship between the chemicals and the distribution of morphologic alterations of the lumbosacral primary sensory neuron, one of the most vulnerable targets of the neurotoxic substances (Thomas, 1980).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Species:
- rat
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Test rats developed mild ataxia in the hindleg in the second and third week of the fifth month of inhalation exposure (Ohnishi, 1993). Test rats were sacrificed at the end of the fifth month of exposure along with the pair-fed control rats. In teased fiber preparations of peroneal, proximal, and distal sural nerves, nerve to soleus muscle, and proximal and distal dorsal caudal trunks, the difference in the frequency of the abnormality between test and control was not statistically significant. In epon-embedded sections, no abnormality of myelinated fibers in test compared with control was found in the limb nerves and the dorsal caudal trunk. Similarly, no abnormality was found in the sixth lumbar and the third sacral dorsal roots and dorsal root ganglion. On the other hand, in fasciculus gracilis, degeneration of myelinated fibers was found in all test rats at the third cervical segment, but not at the fifth thoracic segment. Morphometric evaluation of peroneal nerve and proximal and distal dorsal caudal trunks showed that the transverse fascicular area, myelinated fiber density, myelinated fiber number per nerve, and median and mean diameters of myelinated fibers were all similar between test and control.
The extent of the distribution of the distal degeneration of the myelinated axon in the fasciculus gracilis was analyzed. The centrally directed myelinated axon of the primary sensory neuron seemed to be dying or degenerating back to the fourth cervical segment and down to the third thoracic segment. The densities and the median diameters of myelinated fibers of the dorsomedì.an portion of the fasciculus gracilis at the third cervical and fifth thoracic segments were evaluated. Myelinated fiber density in test was significantly less than that in control only at the third cervical segment. Median diameter was similar between test and control in both segments.
In BtO intoxication, obvious axonal degeneration of myelinated fibers was preferentially found in the dorsal portion of the fasciculus gracilis, where the centrally directed myelinated axon of the lumbosacrococcygeal primary sensory neuron is distributed.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.